Olema Pharmaceuticals Income Statement (2020-2026) | OLMA

Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter)
11.91M12.52M15.97M16.01M27.05M17.63M21.58M22.83M17.99M19.45M25.87M29.88M29.11M33.23M32.30M30.62M43.90M39.95M43.22M49.23M
Selling, General & Administrative (Quarter)
4.61M5.24M5.78M7.25M6.24M5.59M5.63M6.78M3.61M3.89M4.54M4.46M4.42M4.39M4.47M4.25M3.96M5.93M6.86M8.75M
Operating Expenses (Quarter)
16.52M17.76M21.76M23.25M33.29M23.22M27.22M29.60M21.60M23.34M30.42M34.34M33.53M37.62M36.77M34.87M47.86M45.88M50.08M57.99M
Operating Income (Quarter)
-16.52M-17.76M-21.76M-23.25M-33.29M-23.22M-27.22M-29.60M-21.60M-23.34M-30.42M-34.34M-33.53M-37.62M-36.77M-34.87M-47.86M-45.88M-50.08M-57.99M
EBIT (Quarter)
-16.52M-17.76M-21.76M-23.25M-33.29M-23.22M-27.22M-29.60M-21.60M-23.34M-30.42M-34.34M-33.53M-37.62M-36.77M-34.87M-47.86M-45.88M-50.08M-57.99M
Non-operating items
Interest & Investment Income (Quarter)
0.12M0.10M0.11M0.22M0.41M0.62M0.97M1.30M1.55M1.92M3.55M3.35M3.11M2.93M3.29M4.52M4.04M3.65M4.01M4.78M
Other Non Operating Income (Quarter)
-0.00M-0.06M0.01M0.01M0.02M-0.12M0.07M0.01M-0.04M-0.08M0.09M0.02M0.04M0.14M-0.09M-0.04M0.04M0.01M0.01M0.12M
Non Operating Income (Quarter)
0.12M0.05M0.12M0.22M0.43M0.50M1.04M1.32M1.51M1.84M3.64M3.37M3.15M3.07M3.20M4.48M4.08M3.66M4.02M4.90M
Net income details
EBT (Quarter)
-16.41M-17.66M-21.65M-23.04M-32.88M-22.60M-26.25M-28.30M-20.05M-21.42M-26.86M-30.99M-30.42M-34.69M-33.47M-30.35M-43.82M-42.23M-46.07M-53.21M
Profit After Tax (Quarter)
-16.41M-17.71M-21.64M-23.03M-32.86M-22.72M-26.18M-28.29M-20.09M-21.50M-26.77M-30.97M-30.38M-34.55M-33.57M-30.39M-43.78M-42.22M-46.06M-53.09M
Income from Continuing Operations (Quarter)
-16.41M-17.66M-21.65M-23.04M-32.88M-22.60M-26.25M-28.30M-20.05M-21.42M-26.86M-30.99M-30.42M-34.69M-33.47M-30.35M-43.82M-42.23M-46.07M-53.21M
Consolidated Net Income (Quarter)
-16.41M-17.66M-21.65M-23.04M-32.88M-22.60M-26.25M-28.30M-20.05M-21.42M-26.86M-30.99M-30.42M-34.69M-33.47M-30.35M-43.82M-42.23M-46.07M-53.21M
Income towards Parent Company (Quarter)
-16.41M-17.66M-21.65M-23.04M-32.88M-22.60M-26.25M-28.30M-20.05M-21.42M-26.86M-30.99M-30.42M-34.69M-33.47M-30.35M-43.82M-42.23M-46.07M-53.21M
Net Income towards Common Stockholders (Quarter)
-16.41M-17.71M-21.64M-23.04M-32.88M-22.60M-26.25M-28.30M-20.05M-21.42M-26.86M-30.99M-30.42M-34.69M-33.47M-30.35M-43.82M-42.23M-46.07M-53.21M
Additional items
EPS (Basic) (Quarter)
-0.42-0.45-0.55-0.58-0.82-0.57-0.65-0.70-0.49-0.48-0.48-0.56-0.54-0.60-0.40-0.36-0.51-0.49-0.51-0.52
EPS (Weighted Average and Diluted) (Quarter)
-0.42-0.45-0.55-0.58-0.82-0.57-0.65-0.70-0.49-0.48-0.48-0.56-0.54-0.60-0.40-0.36-0.51-0.49-0.51-0.52
Shares Outstanding (Weighted Average) (Quarter)
39.37M39.61M39.52M39.83M39.92M39.93M40.00M40.35M40.47M42.00M45.25M55.57M56.28M57.26M58.74M85.43M85.50M85.73M87.01M102.80M
Shares Outstanding (Diluted Average) (Quarter)
39.42M39.61M39.52M39.83M39.92M40.04M40.00M40.35M40.47M44.98M45.25M55.57M56.28M57.26M58.74M85.43M85.46M85.55M87.01M102.80M
EBITDA (Quarter)
-16.41M-17.68M-21.80M-24.51M-33.63M-23.00M-25.32M-27.45M-19.64M-21.23M-26.18M-31.33M-30.49M-33.97M-33.89M-30.11M-43.89M-42.01M-45.97M-54.17M
Interest Expenses (Quarter)
Shares Outstanding (Quarter)
39.55M39.68M39.80M39.87M39.97M40.08M40.29M40.44M41.12M54.60M54.99M55.87M57.25M57.29M74.31M68.33M68.63M68.65M81.38M87.33M